Tapewire

Nasdaq · USD

ADAG

Adagene Inc.

Export transactions ↓
Tapewire entity
6155
SEC CIK
0001818838
Parsed reports
19

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202630
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 23, 2026 Filed Sep 25, 2026 22:23 UTC
Tam Man KinDirector · Chief Financial Officer
PurchaseAmerican Depositary Shares (ADSs) 2,000 $3.00 $6,000.00
Disclosure

SEC source: 0001104659-26-111069 · tm2626073-1_4seq1.xml · nonDerivative · entry 1

Tam Man Kin · CIK 0002106478 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

F1 · balance_after: Including (i) 2,000 ADSs bought in the open market on 9/23/2026 at $3/ADS and (ii) vesting of Restricted Stock Unit (RSU) on 7/23/2026, which corresponds to 10,000 ADSs or 12,500 ordinary shares. Such RSU was granted under the 2021 Performance Incentive Plan in July 2024.

Read SEC document
September 16, 2026 Filed Sep 17, 2026 10:11 UTC
Luo PeterDirector · Chief Executive Officer
PurchaseAmerican Depositary Shares (ADS) 20,290 $3.15 $63,980.46
Disclosure

SEC source: 0001104659-26-108386 · tm2625620-1_4seq1.xml · nonDerivative · entry 1

Luo Peter · CIK 0001907614 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,535

F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.20 per share.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 22:11 UTC
DO CUONG VDirector
PurchaseAmerican Depositary Shares (ADS) 2,000 $3.75 $7,500.00
Disclosure

SEC source: 0001104659-26-098426 · tm2623261-4_4seq1.xml · nonDerivative · entry 1

DO CUONG V · CIK 0001477037 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

F1 · shares: These shares were purchased in multiple transactions at prices $3.75 per share.

Read SEC document
August 13, 2026 Filed Aug 14, 2026 15:20 UTC GrantNonqualified Stock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0002120696-26-000002 · primary_doc.xml · derivative · entry 1

Grawunder Ulf · CIK 0002120696 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-08-13

Read SEC document
August 13, 2026 Filed Aug 18, 2026 00:32 UTC
Zhu LiDirector
GrantNonqualified Stock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001104659-26-097996 · tm2623261-3_4seq1.xml · derivative · entry 1

Zhu Li · CIK 0002104427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-08-13

F1 · derivative.exercise_date: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.

Read SEC document
August 13, 2026 Filed Aug 18, 2026 00:30 UTC GrantNonqualified Stock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001104659-26-097995 · tm2623261-1_4seq1.xml · derivative · entry 1

Cheung Andy Yiu Leung · CIK 0002110863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-08-13

F1 · derivative.exercise_date: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.

Read SEC document
August 13, 2026 Filed Aug 18, 2026 00:30 UTC
DO CUONG VDirector
GrantNonqualified Stock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001104659-26-097994 · tm2623261-2_4seq1.xml · derivative · entry 1

DO CUONG V · CIK 0001477037 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-08-13

F1 · derivative.exercise_date: 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.

Read SEC document
August 05, 2026 Filed Aug 6, 2026 22:15 UTC
Luo PeterDirector · Chief Executive Officer
PurchaseAmerican Depositary Shares (ADS) 279 $3.65 $1,018.35
Disclosure

SEC source: 0001104659-26-092176 · tm2622406-1_4seq1.xml · nonDerivative · entry 2

Luo Peter · CIK 0001907614 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,245

Read SEC document
August 04, 2026 Filed Aug 6, 2026 22:15 UTC
Luo PeterDirector · Chief Executive Officer
PurchaseAmerican Depositary Shares (ADS) 22,966 $3.65 $83,745.52
Disclosure

SEC source: 0001104659-26-092176 · tm2622406-1_4seq1.xml · nonDerivative · entry 1

Luo Peter · CIK 0001907614 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,966

F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.65 per share.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.